Company intelligence / Profile preview

IPharmatrials

Brooklyn, New York, United States

Ownership: Private
Development stage: Other

Overview

IPharmatrials is a pharmaceutical company founded by Dr. Ranga Chelva Krishna, a prominent New York-based neurologist, to develop cannabinoid-based treatments for chronic and terminal illnesses. The company operates in close collaboration with IGC Pharma (formerly India Globalization Capital), focusing on leveraging the therapeutic potential of medical marijuana and CBD. Its lead candidate, IGC-AD1, is a low-dose THC formulation currently in Phase 2 clinical trials for managing agitation associated with Alzheimer's disease. IPharmatrials also holds several patents and conducts research into treatments for epilepsy, chronic pain, and cachexia. The company maintains a presence in both the United States and India, utilizing its clinical expertise to advance its pipeline of cannabinoid therapies.

Therapeutic areas: OncologyNeurologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Partnerships

IGC Pharma

Beyond the preview

Go deeper on IPharmatrials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPharmatrials.

Explore the full profile